• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

iGlucose Integrates with Validic’s Data Connectivity Platform to Simplify Diabetes Management

by Fred Pennic 08/07/2018 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

 

iGlucose Integrates with Validic's Data Connectivity Platform to Simplify Diabetes Management

Smart Meter, LLC, makers of the iGlucose® Cellular Diabetes Care Solution, announced its integration with Validic, a healthcare data connectivity platform. The integration brings a simple, convenient and affordable diabetes management solution to people with diabetes, healthcare teams, and population management programs. 

The iGlucose solution, which uses cell-enabled technology to automatically transmit real-time blood glucose results, removes complex technology issues by automatically transmitting real-time blood glucose (BG) results that can be viewed and acted on by a healthcare team. 

With the integration of iGlucose into the Validic platform, health systems and corporate wellness leaders can now offer an effective diabetes management program that fits easily into busy lives. When an iGlucose user checks their blood glucose, the healthcare team can receive near real-time, actionable data and has the information to confidently treat their patients. 

The iGlucose Solution eliminates the day-to-day hassles of cables, syncing devices and downloading apps for people with diabetes. Healthcare teams can easily engage patients by viewing real-time results and seeing when their patients’ BG results are out of range. iGlucose enables and supports the new CMS reimbursable remote patient monitoring program (CPT 99091) that requires patient-generated, digitally stored data.

 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Blood Glucose Monitor, CMS, Corporate Wellness, diabetes, diabetes app, Diabetes Management, Diabetes Management Platform, glucose data, Health Systems, Healthcare Data, Patient Monitoring, remote patient monitoring, Validic

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |